Mercado de filtros de sangre: mapeo competitivo y perspectivas estratégicas para 2031

  • Report Code : TIPRE00008206
  • Category : Medical Device
  • Status : Published
  • No. of Pages : 206
Buy Now

Se prevé que el mercado de filtros de sangre alcance los 535,634 millones de dólares en 2028, desde los 405,226 millones de dólares en 2021; se estima que crecerá a una tasa compuesta anual del 4,1 % entre 2021 y 2028.

Un filtro de sangre es un filtro tipo pantalla compuesto de malla tejida hecha de poliéster o nailon. , y se coloca entre la bolsa de producto y el paciente para realizar la filtración. Estos filtros están destinados a proteger a los pacientes de macroagregados y partículas no pertenecientes a componentes sanguíneos que podrían ser peligrosos si ingresan al torrente sanguíneo. Eliminan macroagregados, como sitios de microagregados y agregados de fibrina, durante una transfusión de sangre. La filtración implica capturar partículas y macroagregados elaborados a partir de leucocitos, fibrina y plaquetas, formados durante el almacenamiento de sangre. Factores como un aumento de la carga de enfermedades crónicas, un aumento de los casos de traumatismos y accidentes y un número creciente de procedimientos de transfusión de sangre impulsan el crecimiento del mercado de filtros de sangre. Sin embargo, las retiradas de productos obstaculizan el crecimiento del mercado.

Perspectivas estratégicas

regiones lucrativas para los filtros de sangre Mercado

Perspectivas del mercado

El creciente número de procedimientos de transfusión de sangre refuerza el crecimiento del mercado de filtros de sangre

Mejorar la disponibilidad de productos seguros y La sangre adecuada para los procedimientos de transfusión debe ser una parte integral de la infraestructura y la política sanitaria nacional de cada país. La necesidad de transfusión de sangre puede surgir en cualquier momento en zonas urbanas y rurales. En el pasado, la falta de disponibilidad de sangre provocó la muerte de muchos pacientes por problemas de salud. Se puede garantizar un suministro adecuado y fiable de sangre segura si se cuentan con instalaciones estables para los donantes de sangre regulares, voluntarios y no remunerados. También son el grupo de donantes más seguro ya que la prevalencia de infecciones transmitidas por la sangre es la más baja entre estos donantes.

Las cirugías más comunes que requieren transfusión de sangre incluyen procedimientos cardiovasculares, Procedimientos de cesárea y lesiones. Según estimaciones del Instituto Nacional del Corazón, los Pulmones y la Sangre y los Institutos Nacionales de Salud (NIH), en los EE. UU., más de 5 millones de personas necesitan transfusiones de sangre cada año. Además, debido a las calamidades naturales y las bajas generalizadas, la demanda de transfusiones de sangre está aumentando en todo el mundo. Un aumento en la incidencia de trastornos sanguíneos como anemia, eritrocitosis, leucocitosis, leucopenia y trombocitosis también está impulsando el crecimiento del mercado de filtros sanguíneos. Según la OMS, la mayoría de los niños con talasemia nacen en países de bajos ingresos, donde el acceso a las transfusiones de sangre es difícil o está disponible para un pequeño porcentaje de la población.

Los filtros de sangre utilizados en los procedimientos de transfusión son mallas tejidas hechas de poliéster o nailon; Estos son filtros tipo pantalla colocados entre la bolsa del producto y el paciente. Estos filtros están diseñados para proteger a los pacientes de macroagregados potencialmente dañinos, como plaquetas, leucocitos y proteínas de fibrina, y partículas no componentes de la sangre. En la mayoría de los países desarrollados, los filtros de transfusión de sangre los proporcionan los gobiernos o programas comunitarios. Por lo tanto, la disponibilidad de instalaciones adecuadas para la donación de sangre y de donantes voluntarios impulsa el número de procedimientos de transfusión de sangre, lo que impulsa el crecimiento del mercado de rellenos de sangre.

Información basada en el producto< /h3>

Según el producto, el mercado de filtros de sangre se segmenta aún más en 40 micrones y 70 micrones, 100 micrones y 170 micrones, entre otros. El segmento de 100 micrones y 170 micrones tendría la mayor participación de mercado en 2021 y se espera que registre una CAGR más alta durante el período de pronóstico.

Mercado de filtros de sangre, por producto: 2021 y 2028


Perspectivas basadas en materiales

Basado en materiales, el mercado de filtros de sangre se segmenta en policarbonato, poliéster, ABS y otros. El segmento del poliéster tendría la mayor cuota de mercado del 35,47% en 2021, y se espera que mantenga su dominio durante el período de pronóstico.

Información basada en aplicaciones

Según la aplicación, el mercado de filtros de sangre se segmenta en procesamiento de sangre y transfusión de sangre. El segmento de transfusión de sangre tendría la mayor cuota de mercado del 73,83% en 2021, y se espera que mantenga su dominio durante el período de pronóstico.

Información basada en el usuario final

Según el usuario final, el mercado de filtros de sangre se segmenta en bancos de sangre, hospitales y otros. El segmento de bancos de sangre tendría la mayor cuota de mercado del 47,38% en 2021 y se espera que mantenga su dominio durante el período de pronóstico.

Varias empresas que operan en el filtro de sangre El mercado está adoptando estrategias como lanzamientos de productos, fusiones y adquisiciones, colaboraciones, innovaciones de productos y expansiones de cartera de productos para expandir su presencia en todo el mundo, mantener la marca y satisfacer la creciente demanda de los usuarios finales.

Mercado de filtros de sangre: ndash; por Producto

  • 40 Micrones y 70 Micrones
  • 100 Micrones y 170 Micrones
  • Otros

Filtro de Sangre Mercado: por Material

  • Policarbonato
  • Poliéster
  • ABS
  • Otros

Filtro de Sangre Mercado: por aplicación

  • Procesamiento de sangre
  • Transfusión de sangre

Mercado de filtros de sangre: por usuario final

  • Bancos de sangre
  • Hospitales
  • Otros

Mercado de filtros de sangre: por Geografía

  • América del Norte
    • Estados Unidos
    • Canadá
    • México
  • < li>Europa
    • Francia
    • Alemania
    • Italia
    • Reino Unido
    • España
    • Resto de Europa
  • Asia Pacífico (APAC)
    • China
    • India
    • Corea del Sur
    • Japón
    • Australia
    • Resto de Asia Pacífico
  • Medio Oriente y Asia África (MEA)
    • Sudáfrica
    • Arabia Saudita
    • EAU
    • Resto de Medio Oriente y África África
  • Sur y África Centroamérica (SCAM)
    • Brasil
    • Argentina
    • Resto de Sudamérica y Centroamérica
< h3>Perfiles de la empresa
  • Asahi Kasei Corporation
  • Fresenius Kabi AG
  • Macopharma
  • Haemonetics Corporation
  • Infomed SA
  • CORPORACIÓN KANEKA
  • Laboratorios Kawasaki. Inc.
  • Sefar AG
  • Shandong Zhongbaokang Medical Implements Co., Ltd.
  • Nanjing Shuangwei Biotechnology Co., Ltd.
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What is a blood filter?

A blood filter is a screen-type filter composed of woven mesh made from polyester or nylon, and it is placed between the product bag and the patient for performing filtration. These filters are intended to protect patients from macro-aggregates and non-blood component particulate matter that could be hazardous if enter the bloodstream. They remove macro-aggregates such as micro-aggregate sites and fibrin aggregates during a blood transfusion. Filtration involves capturing particles and macro-aggregates made from leucocytes, fibrin, and platelets, formed during blood storage.

What are the driving factors for the blood filter market across the globe?

Key factors that are driving the growth of this market are an increase in the burden of chronic diseases, a surge in cases of trauma and accidents, and a rising number of blood transfusion procedures are expected to boost the market growth for the blood filter over the years.

Which product led the blood filter market?

The 100micron and 170-micron segment dominated the global blood filter market and held the largest revenue share of 56.80% in 2021.

Which material led the blood filter market?

The polyester segment dominated the global blood filter market and held the largest revenue share of 35.47% in 2021.

Which application held the largest share in the blood filter market?

The blood transfusion segment dominated the global blood filter market and accounted for the largest revenue share of 73.83% in 2021

Which end-user held the largest share in the blood filter market?

The blood banks segment dominated the global colon blood filter market and accounted for the largest revenue share of 47.38% in 2021.

Who are the key players in the blood filter market?

The blood filter market majorly consists of players such Asahi Kasei Corporation, Fresenius Kabi AG, Macopharma, Haemonetics Corporation, Infomed SA, KANEKA CORPORATION, Kawasumi laboratories. Inc., Sefar AG, Shandong Zhongbaokang Medical Implements Co., Ltd, Nanjing Shuangwei Biotechnology Co., Ltd. among others.

What is the regional market scenario of the blood filter market?

Global blood filter market is segmented by region into North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America. In North America, The US holds the largest size of the market in this region. Nearly 16 million blood components are transfused each year in the U.S. According to the American Cancer Society, more than 1.8 million people are expected to be diagnosed with cancer in 2020. Many of them will need blood, sometimes daily, during their chemotherapy treatment. Blood products are transfused through intravenous tubing with filters. The filters, which typically have pore diameters of 170 to 260 microns, are used to prevent particulate debris from being administered as well. The trapped material promotes bacterial growth, and the American Association of Blood Banks (AABB) recommends not using a filter for more than 4 hours. The government is also experiencing increasing chronic conditions such as acute kidney injury (AKI), multiple organ dysfunction syndromes, or sepsis. Thus, it is expected that rising incidences of chronic diseases are likely to influence the market's growth. Moreover, the rise in transplant procedures across the United States is expected to increase the blood transfer procedures that require collection units such as tubes, bags, and others. According to the Red Cross Blood Center, 4.5 million Americans require blood transfusion annually.

The List of Companies - Blood Filter Market

  1. Asahi Kasei Corporation
  2. Fresenius Kabi AG
  3. Macopharma
  4. Haemonetics Corporation
  5. Infomed SA
  6. KANEKA CORPORATION
  7. Kawasumi laboratories. Inc.
  8. Sefar AG
  9. Shandong Zhongbaokang Medical Implements Co., Ltd.
  10. Nanjing Shuangwei Biotechnology Co., Ltd.

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports